Lombard Odier Asset Management (USA)’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,862	Closed	-$186K	–	271
2024 Q2	$186K	Buy	10,862 +557	+5%	+$9.54K	0.01%	167
2024 Q1	$161K	Buy	+10,305	New	+$161K	﹤0.01%	210
2020 Q3	–	Sell	-8,000	Closed	-$474K	–	190
2020 Q2	$474K	Buy	+8,000	New	+$474K	0.03%	137